PowerShares Dynamic Biotechnology & Genome Portfolio (PBE) ETF

Expense Ratio: 0.50% | AUM: 224.49M | Issuer: Invesco PowerShares

PBE Daily Price Range
PBE 52-Week Price Range

PBE - Real-Time SMART Grade™

A
Strong Buy

Overall SMART Grade

PBE has a real-time SMART Grade of A (Strong Buy).

Learn More About SMART Grades™

PBE - Profile & Info


The investment objective of the PowerShares Dynamic Biotech & Genome ETF is based on the Dynamic Biotech & Genome Intellidex. The Underlying Intellidex Index is comprised of common stocks of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances in biotechnology and genetic engineering and research.

Issuer Invesco PowerShares
Expense Ratio 0.50%
Assets Under Management (AUM) 224.49M
Underlying Index Dynamic Biotechnology & Genome Intellidex Index
Asset Class Equity
ETF Category Health & Biotech ETFs
Net Asset Value (NAV) $41.96
Options? No
Total Holdings 32

PBE - Top Holdings

Symbol Holding Name % of Total
INCY Incyte Corp 6.00%
VRTX Vertex Pharmaceuticals Inc 5.28%
REGN Regeneron Pharmaceuticals Inc 5.28%
AMGN Amgen Inc 5.03%
BMRN BioMarin Pharmaceutical Inc 4.96%
BIIB Biogen Inc 4.92%
GILD Gilead Sciences Inc 4.73%
ALXN Alexion Pharmaceuticals Inc 4.48%
CORT Corcept Therapeutics Inc 3.08%
ALNY Alnylam Pharmaceuticals Inc 3.06%
INSM Insmed Inc 3.05%
PGNX Progenics Pharmaceuticals Inc 2.96%
ACOR Acorda Therapeutics Inc 2.93%
NBIX Neurocrine Biosciences Inc 2.86%
INVA Innoviva Inc 2.82%
SGEN Seattle Genetics Inc 2.78%
ARRY Array BioPharma Inc 2.75%
EXEL Exelixis Inc 2.74%
RGEN Repligen Corp 2.71%
ZIOP ZIOPHARM Oncology Inc 2.69%
EBS Emergent BioSolutions Inc 2.68%
LXRX Lexicon Pharmaceuticals Inc 2.62%
MYGN Myriad Genetics Inc 2.61%
CSII Cardiovascular Systems Inc 2.60%
UTHR United Therapeutics Corp 2.59%
OPK OPKO Health Inc 2.48%
IONS Ionis Pharmaceuticals Inc 2.44%
MNTA Momenta Pharmaceuticals Inc 2.38%
INSY Insys Therapeutics Inc 2.15%
ANIP ANI Pharmaceuticals Inc 2.06%
DYAX Dyax Corp 0.13%
0.00%

PBE - News


View All PBE News

PBE - Price/Volume Stats

Current price $42.68
Prev. close $41.92
Day low $42.26
Day high $42.86
52-week high $44.43
52-week low $34.41
Day Volume 12,200
Avg. volume 22,462
Dividend yield 0.49%

PBE - Recent Returns

1-mo 0.71%
3-mo 7.75%
6-mo 13.99%
1-year 3.62%
3-year 12.89%
5-year 94.22%
YTD 10.11%
2016 -22.90%
2015 1.72%
2014 36.34%
2013 62.22%
2012 13.86%

PBE - Stock Chart


PBE - Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
Page generated in 2.209 seconds.